Intellectual Property partner John M. Griem, Jr. participated in the 4th Annual Paragraph IV Disputes Master Symposium in Chicago September 19-20, 2016. Mr. Griem’s panel, “Assessing the True Measure of Damages in an At-Risk Launch Scenario,” considered the factors governing an award of damages arising from the “at risk” launch of generic pharmaceutical product later found to infringe.